Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Breakthrough Genomics, |
RCV000676589 | SCV005292490 | benign | not provided | criteria provided, single submitter | not provided | ||
| Gene |
RCV000676589 | SCV001896261 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000676589 | SCV001728137 | benign | not provided | 2025-01-25 | criteria provided, single submitter | clinical testing | |
| Mayo Clinic Laboratories, |
RCV000676589 | SCV000802376 | likely benign | not provided | 2016-03-02 | no assertion criteria provided | clinical testing | |
| Genome |
RCV000509123 | SCV000606876 | not provided | Combined oxidative phosphorylation defect type 15 | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |